Have a feature idea you'd love to see implemented?
Let us know!
IRIX Iridex Corp
Price (delayed)
$1.64
Market cap
$27.28M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.67
Enterprise value
$28.33M
Iridex Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company's proprietary MicroPulse®
Highlights
Iridex's debt has soared by 114% from the previous quarter and by 69% YoY
IRIX's equity has dropped by 78% year-on-year and by 38% since the previous quarter
Key stats
What are the main financial stats of IRIX
Market
Valuations
Earnings
Shares outstanding
16.64M
Market cap
$27.28M
Enterprise value
$28.33M
Price to earnings (P/E)
N/A
Price to book (P/B)
10.32
Price to sales (P/S)
0.56
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.58
Revenue
$48.43M
Gross profit
$18.8M
Net income
-$11.04M
EBIT
-$10.9M
EBITDA
-$9.08M
Free cash flow
-$7M
Per share
Balance sheet
Liquidity
EPS
-$0.67
EPS diluted
-$0.67
Free cash flow per share
-$0.42
Book value per share
$0.16
Revenue per share
$2.92
TBVPS
$1.68
Total assets
$30.15M
Total liabilities
$27.53M
Debt
$4.91M
Equity
$2.62M
Working capital
$8.49M
Debt to equity
1.87
Current ratio
1.54
Quick ratio
0.73
Net debt/EBITDA
-0.12
Margins
Efficiency
Dividend
EBITDA margin
-18.7%
Gross margin
38.8%
Net margin
-22.8%
Operating margin
-22.5%
Return on assets
-34%
Return on equity
-192.9%
Return on invested capital
-85.5%
Return on capital employed
-76.2%
Return on sales
-22.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IRIX stock price
How has the Iridex stock price performed over time
Intraday
-4.09%
1 week
-4.65%
1 month
-5.75%
1 year
-37.16%
YTD
-41.64%
QTD
-6.29%
Financial performance
How have Iridex's revenue and profit performed over time
Revenue
$48.43M
Gross profit
$18.8M
Operating income
-$10.88M
Net income
-$11.04M
Gross margin
38.8%
Net margin
-22.8%
Iridex's net margin has plunged by 61% YoY and by 4.6% from the previous quarter
The operating margin has declined by 47% year-on-year and by 4.7% since the previous quarter
The net income is down by 42% YoY
IRIX's operating income is down by 31% year-on-year
Growth
What is Iridex's growth rate over time
Valuation
What is Iridex stock price valuation
P/E
N/A
P/B
10.32
P/S
0.56
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.58
The EPS has decreased by 40% YoY
The price to book (P/B) is 179% higher than the 5-year quarterly average of 3.7 and 29% higher than the last 4 quarters average of 8.0
IRIX's equity has dropped by 78% year-on-year and by 38% since the previous quarter
The stock's price to sales (P/S) is 49% less than its 5-year quarterly average of 1.1 and 30% less than its last 4 quarters average of 0.8
The revenue has declined by 11% year-on-year and by 2.6% since the previous quarter
Efficiency
How efficient is Iridex business performance
The company's return on assets has shrunk by 70% YoY and by 6% QoQ
IRIX's return on invested capital has dropped by 67% year-on-year and by 9% since the previous quarter
The ROS has shrunk by 60% YoY and by 4.2% QoQ
Iridex's ROE has decreased by 44% from the previous quarter
Dividends
What is IRIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IRIX.
Financial health
How did Iridex financials performed over time
Iridex's total assets is 10% higher than its total liabilities
The quick ratio has dropped by 53% year-on-year and by 2.7% since the previous quarter
The company's current ratio fell by 42% YoY
Iridex's debt is 87% more than its equity
Iridex's debt has soared by 114% from the previous quarter and by 69% YoY
IRIX's equity has dropped by 78% year-on-year and by 38% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.